PharmaSGP Holding SE
FSX:PSG.DE
24 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 28.162 | 30.205 | 25.424 | 25.966 | 25.698 | 24.011 | 21.878 | 21.952 | 21.426 | 20.568 | 19.179 | 19.734 | 14.081 | 12.35 | 14.69 | 14.747 | 17.071 | 16.738 | 16.852 | 14.171 | 16.596 | 14.955 |
Cost of Revenue
| 2.615 | 6.918 | 6.841 | 2.349 | 2.375 | 2.275 | 2.157 | 2.17 | 2.292 | 2.413 | 2.522 | 1.642 | 1.239 | 1.085 | 2.038 | 1.411 | 1.545 | 1.212 | 1.483 | 1.349 | 1.432 | 1.604 |
Gross Profit
| 25.547 | 23.287 | 18.583 | 23.617 | 23.323 | 21.736 | 19.721 | 19.782 | 19.134 | 18.155 | 16.657 | 18.092 | 12.842 | 11.265 | 12.652 | 13.336 | 15.526 | 15.526 | 15.369 | 12.822 | 15.164 | 13.351 |
Gross Profit Ratio
| 0.907 | 0.771 | 0.731 | 0.91 | 0.908 | 0.905 | 0.901 | 0.901 | 0.893 | 0.883 | 0.869 | 0.917 | 0.912 | 0.912 | 0.861 | 0.904 | 0.909 | 0.928 | 0.912 | 0.905 | 0.914 | 0.893 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 1.866 | 2.696 | 1.791 | 0 | 0 | 0 | -26.748 | 1.425 | 1.55 | 1.401 | -21.431 | -3.068 | -6.045 | 0 | 1.039 | -1.051 | 1.039 | 0 | 0.305 | -0.555 | 0.57 | 0.613 |
Selling & Marketing Expenses
| 13.098 | 14.3 | 9.819 | 10.814 | 11.428 | 11.32 | 37.378 | 8.677 | 9.124 | 10.431 | 30.843 | 13.358 | 13.358 | 0 | 31.646 | 15.936 | 15.936 | 0 | 27.824 | 15.5 | 7.9 | 7.6 |
SG&A
| 13.098 | 16.996 | 11.61 | 10.814 | 11.428 | 11.32 | 10.63 | 10.102 | 10.674 | 11.832 | 9.412 | 10.29 | 7.313 | 8.239 | 32.685 | 14.885 | 16.975 | 0.644 | 28.129 | 14.945 | 8.47 | 8.213 |
Other Expenses
| 0.033 | 0.034 | 0.046 | 0.053 | 0.044 | 0.029 | 0.211 | 0.065 | 0.068 | 0.042 | 0.045 | 0.077 | 0.036 | 0.036 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 19.71 | 16.962 | 11.564 | 16.629 | 17.265 | 17.034 | 14.993 | 13.834 | 14.767 | 15.515 | 12.49 | 12.357 | 8.821 | 9.696 | 10.632 | 9.929 | 9.192 | 11.213 | 5.179 | 7.575 | 9.878 | 9.591 |
Operating Income
| 6.641 | 6.325 | 7.019 | 7.895 | 6.265 | 4.977 | 4.855 | 5.948 | 4.367 | 2.64 | 3.524 | 5.735 | 4.021 | 1.569 | 0.166 | 4.53 | 5.214 | 4.314 | 8.026 | 5.248 | 5.286 | 3.76 |
Operating Income Ratio
| 0.236 | 0.209 | 0.276 | 0.304 | 0.244 | 0.207 | 0.222 | 0.271 | 0.204 | 0.128 | 0.184 | 0.291 | 0.286 | 0.127 | 0.011 | 0.307 | 0.305 | 0.258 | 0.476 | 0.37 | 0.319 | 0.251 |
Total Other Income Expenses Net
| -1.152 | -0.243 | -0.702 | -1.5 | -0.942 | -1.119 | -0.512 | -0.696 | -0.399 | -0.4 | -0.314 | -0.303 | -0.011 | -0.015 | 0.024 | -0.028 | -0.049 | -0.022 | -0.063 | -0.009 | 0.015 | 0 |
Income Before Tax
| 5.489 | 6.082 | 6.317 | 6.395 | 5.323 | 3.858 | 4.343 | 5.252 | 3.968 | 2.24 | 3.21 | 5.432 | 4.01 | 1.554 | 0.19 | 4.502 | 5.165 | 4.292 | 7.963 | 5.239 | 5.301 | 3.76 |
Income Before Tax Ratio
| 0.195 | 0.201 | 0.248 | 0.246 | 0.207 | 0.161 | 0.199 | 0.239 | 0.185 | 0.109 | 0.167 | 0.275 | 0.285 | 0.126 | 0.013 | 0.305 | 0.303 | 0.256 | 0.473 | 0.37 | 0.319 | 0.251 |
Income Tax Expense
| 1.371 | 1.523 | 1.568 | 1.609 | 1.306 | 1.013 | 1 | 1.306 | 0.984 | 0.559 | 0.817 | 1.336 | 0.987 | 0.376 | 0.078 | 1.08 | 1.296 | 1.055 | 2.123 | 1.258 | 1.275 | 0.901 |
Net Income
| 4.118 | 4.559 | 4.749 | 4.786 | 4.017 | 2.845 | 3.343 | 3.946 | 2.984 | 1.681 | 2.393 | 4.096 | 3.023 | 1.178 | 0.112 | 3.422 | 3.869 | 3.237 | 5.84 | 3.981 | 4.026 | 2.859 |
Net Income Ratio
| 0.146 | 0.151 | 0.187 | 0.184 | 0.156 | 0.118 | 0.153 | 0.18 | 0.139 | 0.082 | 0.125 | 0.208 | 0.215 | 0.095 | 0.008 | 0.232 | 0.227 | 0.193 | 0.347 | 0.281 | 0.243 | 0.191 |
EPS
| 0.34 | 0.38 | 0.4 | 0.4 | 0.34 | 0.24 | 0.28 | 0.33 | 0.25 | 0.14 | 0.2 | 0.34 | 0.25 | 0.1 | 0.009 | 0.29 | 0.32 | 0.27 | 0.48 | 0.34 | 0.33 | 0.237 |
EPS Diluted
| 0.34 | 0.38 | 0.4 | 0.4 | 0.34 | 0.24 | 0.28 | 0.33 | 0.25 | 0.14 | 0.2 | 0.34 | 0.25 | 0.1 | 0.009 | 0.29 | 0.32 | 0.27 | 0.48 | 0.34 | 0.33 | 0.237 |
EBITDA
| 8.988 | 8.659 | 9.381 | 10.236 | 8.622 | 7.288 | 7.219 | 8.267 | 6.668 | 4.906 | 5.889 | 6.606 | 4.194 | 1.733 | 0.308 | 4.658 | 5.324 | 4.42 | 8.132 | 5.345 | 5.447 | 3.793 |
EBITDA Ratio
| 0.319 | 0.287 | 0.369 | 0.394 | 0.336 | 0.304 | 0.33 | 0.377 | 0.311 | 0.239 | 0.307 | 0.335 | 0.298 | 0.14 | 0.021 | 0.316 | 0.312 | 0.264 | 0.483 | 0.377 | 0.328 | 0.254 |